# Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access

> **NCT01003990** · PHASE3 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 710 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Atazanavir
- **DRUG:** Atazanavir/Ritonavir
- **DRUG:** Tenofovir/Emtricitabine
- **DRUG:** Lopinavir/ritonavir

## Key facts

- **NCT ID:** NCT01003990
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 710 (ACTUAL)
- **Last updated:** 2017-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01003990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01003990, "Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01003990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*